Interferon-γ deficiency reveals that 129Sv mice are inherently more susceptible to Anaplasma phagocytophilum than C57BL/6 mice

FEMS Immunology and Medical Microbiology

Volumn 42, Issue 3, 2004, Pages 299-305

  Wang, Tian ^a   Akkoyunlu, Mustafa ^a   Banerjee, Rila ^a   Fikrig, Erol ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal mode; Ehrlichiosis; Interferon ; Tick

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN GP 91; INTERLEUKIN 12;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; CHEMOKINES; CHEMOKINES, CXC; DISEASE SUSCEPTIBILITY; EHRLICHIOSIS; FEMALE; GENE DELETION; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; RESPIRATORY BURST;

EID: 5144228357     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.06.001     Document Type: Article

References (25)

1. Bakken J.S., Dumler J.S. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31:2000;554-560
2. Chen S.M., Dumler J.S., Bakken J.S., Walker D.H. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:1994;589-595
3. Klein M.B., Hu S., Chao C.C., Goodman J.L. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J. Infect. Dis. 182:2000;200-205
4. Klein M.B., Hayes S.F., Goodman J.L. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infect. Immun. 66:1998;3410-3415
5. Goodman J.L., Nelson C., Vitale B., Madigan J.E., Dumler J.S., Kurtti T.J., Munderloh U.G. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334:1996;209-215
6. Dumler J.S., Trigiani E.R., Bakken J.S., Aguero-Rosenfeld M.E., Wormser G.P. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin. Diagn. Lab. Immunol. 7:2000;6-8
7. Martin M.E., Caspersen K., Dumler J.S. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am. J. Pathol. 158:2001;1881-1888
8. Mott J., Rikihisa Y. Human granulocytic ehrlichiosis agent inhibits superoxide anion generation by human neutrophils. Infect. Immun. 68:2000;6697-6703
9. Hodzic E., Ijdo J.W., Feng S., Katavolos P., Sun W., Maretzki C.H., Fish D., Fikrig E., Telford S.R., Barthold S.W. Granulocytic ehrlichiosis in the laboratory mouse. J. Infect. Dis. 177:1998;737-745
10. Sun W., Ijdo J.W., Telford S.R. Jr., Hodzic E., Zhang Y., Barthold S.W., Fikrig E. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J. Clin. Invest. 100:1997;3014-3018
11. Borjesson D.L., Simon S.I., Tablin F., Barthold S.W. Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. J. Infect. Dis. 184:2001;1475-1479
12. Borjesson D.L., Barthold S.W. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions. Comp. Med. 52:2002;403-413
13. Martin M.E., Bunnell J.E., Dumler J.S. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J. Infect. Dis. 181:2000;374-378
14. Wang T., Malawista S.E., Pal U., Grey M., Meek J., Akkoyunlu M., Thomas V., Fikrig E. Superoxide anion production during Anaplasma phagocytophila infection. J. Infect. Dis. 186:2002;274-280
15. Akkoyunlu M., Fikrig E. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68:2000;1827-1833
16. Cantin E., Tanamachi B., Openshaw H., Mann J., Clarke K. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1infection than IFN-gamma ligand null-mutant mice. J. Virol. 73:1999;5196-5200
17. Kim H.Y., Rikihisa Y. Roles of p38 mitogen-activated protein kinase, NF-kappaB, and protein kinase C in proinflammatory cytokine mRNA expression by human peripheral blood leukocytes, monocytes, and neutrophils in response to Anaplasma phagocytophila. Infect. Immun. 70:2002;4132-4141
18. Luan J., Furuta Y., Du J., Richmond A. Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. Cytokine. 14:2001;253-263
19. Zhang X.W., Liu Q., Wang Y., Thorlacius H. CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br. J. Pharmacol. 133:2001;413-421
20. Ethuin F., Delarche C., Benslama S., Gougerot-Pocidalo M.A., Jacob L., Chollet-Martin S. Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils. J. Leukoc. Biol. 70:2001;439-446
21. Al-Mohanna F., Saleh S., Parhar R.S., Collison K. IL-12-dependent nuclear factor-kappaB activation leads to de novo synthesis and release of IL-8 and TNF-alpha in human neutrophils. J. Leukoc. Biol. 72:2002;995-1002
22. Akkoyunlu M., Malawista S.E., Anguita J., Fikrig E. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect. Immun. 69:2001;5577-5588
23. Herron M.J., Nelson C.M., Larson J., Snapp K.R., Kansas G.S., Goodman J.L. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science. 288:2000;1653-1656
24. Carlyon J.A., Akkoyunlu M., Xia L., Yago T., Wang T., Cummings R.D., McEver R.P., Fikrig E. Murine neutrophils require alpha1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood. 102:2003;3387-3395
25. Smith L., Bonafonate M., Mead J. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvun-infected gamma-interferon knockout mice. J. Parasitol. 86:2000;300-307